StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results
February 22, 2017 7:52 AM
Wedbush Securities analyst Tao Levy reiterates Neutral rating and $85 price target on Medtronic Plc (NYSE: MDT), suggesting solid results ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Next Articles
Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report
February 22, 2017 9:23 AM
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
February 21, 2017 1:38 PM
Medtronic, Inc. (MDT) PT Raised to $88 at Evercore ISI
February 21, 2017 11:50 AM
Medtronic (MDT) Tops Q3 EPS by 1c; Reiterates Outlook
February 21, 2017 6:50 AM
Form 8-K Medtronic plc For: Feb 21
February 21, 2017 6:47 AM
Medtronic Reports Third Quarter Financial Results
February 21, 2017 6:46 AM
